Integrating innate and adaptive pathways in vaccine responses
Integrating innate and adaptive pathways in vaccine responses
批准号:
8707655
负责人:
JEFFREY Victor RAVETCH
金额:
$243.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2019-03-31
关键词:
AdjuvantAgeAmino Acid SequenceAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntigen-Antibody ComplexAntigensAwardBiologicalCD209 geneCellsClinical SciencesCollaborationsCommunicable DiseasesComplexCouplingDataDendritic CellsDependenceDevelopmentDiseaseEvolutionFDA approvedFamilyFc ReceptorFc domainFucoseFundingGalactoseGenerationsGoalsHelper-Inducer T-LymphocyteHepatitis C virusHumanHumoral ImmunitiesImmune responseImmunityImmunizationImmunoglobulin GImmunoglobulinsImmunologic AdjuvantsImmunologyInfectious AgentInflammatoryIntegration Host FactorsInvestigationLaboratoriesLinkMaintenanceMediatingMediator of activation proteinMedicalMicrobeModificationMolecularMonoclonal Antibody TherapyMusNaturePathway interactionsPeptide Sequence DeterminationPhagocytosisPolysaccharidesProductionRegulationResearchResearch InfrastructureResearch PersonnelResearch Project GrantsRoleRouteSamplingSerumSialic AcidsSpecificityStudy modelsSystemT-LymphocyteTestingTranslational ResearchUniversitiesUniversity HospitalsVaccinationVaccine AdjuvantVaccine DesignVaccinesantibody-dependent cell cytotoxicitybasecytokinedefined contributiondesignmembermonocytenovelnovel vaccinesprogramsreceptorresearch studyresponsevaccine efficacyvirus identificationvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this program is to perform directed investigations into the evolution of lasting, protective Immune responses in humans in order to better understand the requirements of effective vaccines and adjuvants. This application is submitted to obtain funding for a Cooperative Center on Human Immunology at The Rockefeller University. Our program is highly integrated and is based on long-term, productive collaborations between the PIs on defining underlying principles of human immunology, utilizing the infrastructure of the Rockefeller University Hospital, the Zanvil Cohn Vaccine Center and the Rockefeller University Clinical and Translational Science Award (CTSA). The proposed research projects are designed as hypothesis-testing, mechanistic studies, examining novel aspects of the activation and regulation of human immune responses in the context of vaccination against infectious disease. The participating investigators are pioneers in identifying
and characterizing basic mechanisms of the human immune response, having contributed to the initial characterizations of the dendritic cell, the diversity of IgG antibody effector functions ad description of Fc receptors as mediators of immunity, the development of the first models for study of the hepatitis C virus and the Identification of multiple HCV receptors. While significant progress in basic immunology research over the last three decades has resulted in numerous medical advances, a much more substantial understanding of coordinated molecular mechanisms involved in eliciting Immunity will be required to enable judicious vaccine design, particularly for diseases for which no vaccines currently exits. The objective of this proposal is o draw on the broad expertise in immunity and infectious diseases within the collaborating laboratories to define the contributions of critical components, such as dendritic cells, T follicuar helper cells, monocytes and immune complexes in the generation and maintenance of effective immune responses to infectious agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project-003
-
批准号:10170029
-
项目类别:
-
资助金额:$62.61万
-
财政年份:2020
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Integrating innate and adaptive pathways in vaccine responses
-
批准号:10265794
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Project-002
-
批准号:10169069
-
项目类别:
-
资助金额:$87.39万
-
财政年份:2020
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Molecular mechanisms of antibody-mediated immunotherapies
-
批准号:10368931
-
项目类别:
-
资助金额:$99.67万
-
财政年份:2016
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Molecular mechanisms of antibody-mediated immunotherapies
-
批准号:10684073
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2016
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Molecular mechanisms of antibody-mediated immunotherapies
-
批准号:8940844
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2016
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Molecular mechanisms of antibody-mediated immunotherapies
-
批准号:10518790
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2016
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Molecular mechanisms of antibody-mediated immunotherapies
-
批准号:9888968
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2016
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain
-
批准号:8933343
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2015
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Administrative Core
-
批准号:10595523
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Integrating innate and adaptive pathways in vaccine responses
-
批准号:10595522
-
项目类别:
-
资助金额:$208.74万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Integrating innate and adaptive pathways in vaccine responses
-
批准号:9884701
-
项目类别:
-
资助金额:$208.79万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Integrating innate and adaptive pathways in vaccine responses
-
批准号:10386775
-
项目类别:
-
资助金额:$208.75万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Administrative Core
-
批准号:10386776
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Integrating innate and adaptive pathways in vaccine responses
-
批准号:8827238
-
项目类别:
-
资助金额:$243.34万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Fc domain effector activity in dengue disease
-
批准号:10595526
-
项目类别:
-
资助金额:$58.61万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Fc domain effector activity in dengue disease
-
批准号:10386779
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
Integrating innate and adaptive pathways in vaccine responses
-
批准号:9035353
-
项目类别:
-
资助金额:$243.34万
-
财政年份:2014
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
FcR Deficient Mice Susceptibility to Pathogens
-
批准号:8261151
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2011
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
FcR Deficient Mice Susceptibility to Pathogens
-
批准号:8296620
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2011
-
负责人:JEFFREY Victor RAVETCH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: